Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

Phase 3 Completed 84 enrolled Federal University of Rio de Janeiro Rio de Janeiro State Research Supporting Foundation (FAPERJ) · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is conducted to test the hypothesis that in uncontrolled type 2 diabetic adults treatment with diacerein will improve glycemic control and will reduce liver fat within a 24 month period.

Timeline

Start: 2014-10-14
Primary completion: 2017-01-31
Completion: 2018-01-31

Publications

Cardoso CRL, Leite NC, Carlos FO, Loureiro AA, Viegas BB, Salles GF. Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2017 Oct;40(10):1356-1363. doi: 10.2337/dc17-0374. Epub 2017 Aug 17.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Diacerein	Small molecule	50 mg	—

Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

Summary

Timeline

Publications

Drugs

Indications